Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
128 hedge funds and large institutions have $22.8M invested in Ampio Pharmaceuticals Inc. in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 32 reducing their positions, and 11 closing their positions.
775% more call options, than puts
Call options by funds: $674K | Put options by funds: $77K
2% less funds holding
Funds holding: 131 → 128 (-3)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
32% less capital invested
Capital invested by funds: $33.7M → $22.8M (-$10.9M)
38% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 32
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WWM
Western Wealth Management
Golden,
Colorado
|
+$461K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$175K |
| 3 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$162K |
| 4 |
Millennium Management
New York
|
+$57.7K |
| 5 |
NWM
Northcape Wealth Management
Williamsville,
New York
|
+$47.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.95M |
| 2 |
EAM
Empery Asset Management
New York
|
-$2.43M |
| 3 |
D.E. Shaw & Co
New York
|
-$542K |
| 4 |
BIAS
Beacon Investment Advisory Services
Morristown,
New Jersey
|
-$97K |
| 5 |
Barclays
London,
United Kingdom
|
-$94.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EAM
126
Empery Asset Management
New York
| – | -$2.43M | -14,208 | Closed |
|
|
BIAS
127
Beacon Investment Advisory Services
Morristown,
New Jersey
| – | -$97K | -568 | Closed |
|
|
VF
128
Virtu Financial
New York
| – | -$71K | -414 | Closed |
|
|
XT
129
XTX Topco
George Town,
Cayman Islands
| – | -$61K | -359 | Closed |
|
|
AI
130
Atom Investors
Austin,
Texas
| – | -$38K | -223 | Closed |
|
131
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$28 | -162 | Closed |
|
|
TSS
132
Two Sigma Securities
New York
| – | -$14K | -84 | Closed |
|
133
SG Americas Securities
New York
| – | -$13K | -75 | Closed |
|
|
TFS
134
Thoroughbred Financial Services
Brentwood,
Tennessee
| – | -$7K | -44 | Closed |
|
135
Simplex Trading
Chicago,
Illinois
| – | -$3.07K | -21 | Closed |
|
|
EI
136
Ellevest Inc
New York
| – | +$146 | +1 | New |
|
|
CAGAS
137
Capital Advisory Group Advisory Services
Bloomington,
Minnesota
| – | +$438 | +3 | New |
|
AMPE Hedge Fund Activity: Q1 2022 in Review
128 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2022, worth a combined $22.8M — down 32% from $33.7M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of AMPE and 9 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 20 added.
The largest buyer was Western Wealth Management, opening a new position worth an estimated $461K. The largest seller was CVI Holdings, exiting entirely with an estimated $2.95M sold.
- 128 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2022, down from 131 in Q4 2021.
- Funds reported $22.8M of Ampio Pharmaceuticals Inc. stock for Q1 2022, down 32% quarter-over-quarter.
- 9 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2022 and 11 closed out, a net change of -2 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q1 2022 was Western Wealth Management, an estimated $461K added.
- The largest Ampio Pharmaceuticals Inc. seller in Q1 2022 was CVI Holdings, an estimated $2.95M sold.
Based on aggregated 13F filings for Q1 2022.